Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns-Reference-Cited by-同舟云学术

Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns

Published:2011-06 Issue:3 Volume:53 Page:328-331
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:

Author:

Dilmen Ugur,Karagol Belma Saygili,Oguz Serife Suna

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-200X.2010.03245.x/fullpdf

Reference19 articles.

1. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants;Kuzik;J. Pediatr.,2007

2. Hypertonic saline/ epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalizations stay: 2 years experience;Tal;IMAJ,2006

3. Efficacy and safety of nebulized rhDNase as rescue treatment for persistent atelectasis in newborns: Case-series;Erdeve;Croat. Med. J.,2007

4. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis;Mandelberg;Chest,2003

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Human Deoxyribonuclease I;Pharmaceutical Biotechnology;2024

2. Protective effects of Surfacen® in allergen-induced asthma mice model;International Immunopharmacology;2022-01

3. Inhaled Pharmacotherapy for Neonates: A Narrative Review;Turkish Archives of Pediatrics;2021-12-29

4. Is DNase safe and effective in the treatment of refractory atelectasis among preterm neonates?;Archives of Disease in Childhood;2021-11-12

5. A Quality Improvement Approach to Influence Value-based Mucolytic Use in the PICU;Pediatric Quality & Safety;2021-07